Michigan Medicine Updates in Lupus 2022

20 $

‘+ Include: 4 videos + 5 pdfs, size: 811 MB

+ Target Audience: rheumatologist, primary care physican

Description

+ Include: 4 videos + 5 pdfs, size: 811 MB

+ Target Audience: rheumatologist, primary care physican

+ Sample video: contact me for sample video

+ Information:

Description

This course will discuss the basics of lupus management and then broaden to discuss management of lupus nephritis, including a discussion of new FDA approved medications. It will also cover efforts to address disparities in lupus care and outcomes and the latest research ongoing to improve our treatment of lupus patients.

Target Audience

This activity is appropriate for:
House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians

In the fields of:
General Medicine, Internal Medicine, Other Healthcare Professions, Rheumatology

Learning Objectives

At the end of this activity, participants should be able to:

  1. identify the role of hydroxychloroquine in standard of care lupus management.
  2. describe the role of immunosuppressants and which ones to choose in SLE.
  3. list the barriers to proper care in lupus patients.
  4. differentiate the patients that my benefit from voclosporin and belimumab for lupus nephritis.
  5. research new therapies in the pipeline and how they may benefit patients with SLE.

 

 

+ Topics:

Course Syllabus.pdf
Beyond Cyclophosphamide, Treating Lupus Nephritis in the New Millennium.pdf
Beyond Cyclophosphamide, Treating Lupus Nephritis in the New Millennium.ts
Getting to a Cure the Role of Research in SLE.pdf
Getting to a Cure the Role of Research in SLE.ts
Social Determinants of Health and Lupus Care.pdf
Social Determinants of Health and Lupus Care.ts
What is Lupus (Really) and How Do We Treat it.pdf
What is Lupus (Really) and How Do We Treat it.ts

Reviews

There are no reviews yet.

Be the first to review “Michigan Medicine Updates in Lupus 2022”

Your email address will not be published. Required fields are marked *